Scott Barclay leads Point72 Ventures investment activities in healthcare related technologies, with a mission to back ambitious founders leveraging technology and empathy to rebuild healthcare.
Barclay has deep expertise in healthcare and the commercialization and scale of deep tech. Prior to joining Point72 Ventures, Scott was a Partner at DCVC, where he led the Computational Care investment thesis that was focused on backing companies pushing deep compute into healthcare. He invested in and served on the boards of numerous DCVC portfolio companies, including Carbon Health and Medical Informatics Corp. Prior to joining DCVC, he invested and advised broadly in new digital healthcare concepts, helped create and served as Chief Strategy and Product Officer of Surescripts, and led operational and innovation teams across CVS Health.
Previously, Scott worked at The Boston Consulting Group, helped establish a capital markets desk in London for Bank of America Securities, and worked on a manufacturing floor in his hometown in Virginia.
Scott earned his B.A. in History from the University of Virginia and his M.B.A from INSEAD in Fontainebleu, France.
Marta Andres-Terre, PhD is a member of the Healthcare investment team at Point72 Ventures, responsible for diligence and investing in early-stage companies at the forefront of the field of computational care.
Prior to joining Point72, Marta was a consultant at Bain and Company in San Francisco, where she mainly worked on their technology and healthcare practices.
Marta graduated Summa Cum Laude with a B.S. in Biomedical Sciences from the University of Barcelona and a PhD in Immunology from Stanford University. While at Stanford she worked in the Biomedical Informatics and Microbiology departments investigating the immune response to infection, using experimental tools, as well as computational and data science (AI/ML) methods. She was also the president of Stanford’s Biotechnology club.
Katherine Schykerynyc is an Investment Assistant for the Healthcare team, focusing on early stage investments.
Katherine has been in the venture capital industry for over ten years, holding numerous Investment Assistant and Investor Relations roles. She began her career at U.S. Venture Partners, and most recently held roles at Sapphire Ventures and C.M. Capital Advisors.
Originally from the Bay Area, Katherine attended college in the area and majored in Mathematics.
Himanshu Sharma is a Fellow at Point72 Ventures, responsible for diligence and investing in early-stage companies at the intersection of Healthcare and Technology. In this role, he engages with founders to learn about the ideas that are creating an impact in healthcare.
Prior to joining Point72 Ventures, Himanshu was the Genomics Lead at IBM Watson Health, where he led the Watson for Genomics product team in a technical capacity. Prior to that, he was a project manager at Seven Bridges Genomics, a cloud based SAAS platform that enables biomedical informatics analysis. Himanshu started his career in research at Harvard Medical School focusing on Glioblastoma and Partners Healthcare where he led the bioinformatics team.
Himanshu earned his Bachelor’s in Biotechnology from Sinhgad College of Engineering, and his M.S. in Bioinformatics from NYU. He is currently enrolled in the MBA program at The Wharton School of Business.